Abstract
Nocturia is defined as waking during the night at least once to urinate. It has additionally been suggested that a nocturia-related void is preceded and followed by sleep [1]. Whether sleep must follow a nocturia-related void is not entirely clear. Thus, for example, if someone arises an hour earlier than planned with the urge to void but could not return to sleep, nocturia seems evident but would not be considered as such if one rigidly adheres to the notion that a nocturia-related void must be followed by sleep. In the same sense, nocturnal voiding with failure to return to sleep leading to a second void which is then followed by sleep may cause confusion in designation of nocturia severity. Voiding during hours of sleep resulting from awakening for reasons other than the urge to void is not considered nocturia, although from a practical standpoint it is difficult to keep track of “convenience voids” at night as opposed to true nocturia-related voids. Thus, most studies of nocturia in the literature from a practical standpoint include voiding for all reasons during sleep hours.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:179.
Kripke DF, Garfinkel L, Wingard DL, et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59:131.
Bing MH, Moller LA, Jennum P, et al. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60–80 years. BJU Int. 2006;98:599.
Beers T. Flexible schedules and shift work: replacing the ‘9-to-5’ workday? Mon Labor Rev. 2000;23:33–40.
Blanker MH, Bohnen AM, Groeneveld FP, et al. Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men. J Urol. 2000;164:1201.
Weiss JP, Blaivas JG, Stember DS, et al. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn. 1999;18:559.
Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol. 1995;26:1203.
Kirkland JL, Lye M, Levy DW, et al. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J. 1983;287:1665.
van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in nocturia: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:179–83.
Matthiesen TB, Rittig S, Norgaard JP, et al. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol. 1996;156:1292.
Weiss JP, Stember DS, Chaikin DC, Blaivas JG. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn. 1999;18:559–65.
Burton C, Parsons M, Weiss JP, Coats A. Reference values for the nocturnal bladder capacity index. Neurourol Urodyn. 2011;30:52–7.
Weiss JP, Blaivas JG, Jones M, et al. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol. 2007;178:548.
Weiss JP, Blaivas JG, Stember DS, et al. Nocturia in adults: classification and etiology. Neurourol Urodyn. 1997;16:401.
Tikkinen KA, Auvinen A, Johnson 2nd TM, Weiss JP, Keränen T, Tiitinen A, et al. A systematic evaluation of factors associated with nocturia – the population-based FINNO study. Am J Epidemiol. 2009;170(3):361–8.
Adam P. Evaluation and management of diabetes insipidus. Am Fam Physician. 1997;55:2146.
Abraham L, Hareendran A, Mills IW, Martin ML, Abrams P, Drake MJ, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology. 2004;63(3):481–6.
International Consultation on Incontinence modular Questionnaire (ICIQ). [online]. 2006. Available from: http://www.iciq.net/structure.html.
Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
Tikkinen KAO, Johnson TM, Tammela TL, et al. Nocturia frequency, bother and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57(3):488–96.
Nakagawa H, Niu K, Kaiho Y, Ikeda Y, Arai Y. Mortality in the elderly correlates with the frequency of nighttime voiding: results of a 5 year prospective cohort study in Japan. J Urol. 2010;183(4):e1–2.
Asplund R, Aberg H. Nocturnal micturition, sleep and well-being in women of ages 40–64 years. Maturitas. 1996;24(1–2):73–81.
Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol. 2011;185(2):571–7.
Holm-Larsen T, Weiss JP, Langkilde LK. Economic burden of nocturia in the US adult population. J Urol. 2010;183(4):e1.
Ikehara S et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009;32(3):295–301.
Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833–9.
Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2009;10(5):540–8.
Cardozo L et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol. 2004;172:1919–24.
Herschorn S, Swift S, Guan Z, Carlsson M, Morrow JD, Brodsky M, et al. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. BJU Int. 2010;105(1):58–66.
Dmochowski R et al. Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder. Urology. 2010;75(1):62–8.
Brubaker L, Fitzgerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J. 2007;18:737–41.
Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006;67:731–6.
Koseoglu H et al. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology. 2006;67:1188–92.
Speakman M. Efficacy and safety of Tamsulosin OCAS. BJU Int. 2006;98 suppl 2:13–7.
Johnson-II TM, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the department of veterans affairs cooperative study trial. J Urol. 2003;170:145–8.
Johnson-II TM, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol. 2007;178:2045–51.
Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and Tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. A randomized controlled trial. JAMA. 2006;296:2319–28.
Bruskewitz RC, Larsen EH, Madsen PO, Dorflinger T. 3-year follow-up of urinary symptoms after transurethral resection of the prostate. J Urol. 1986;136:613.
Yoshimura K et al. Nocturia and benign prostatic hyperplasia. Urology. 2003;61:786–90.
Cai T et al. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int. 2006;98:799–805.
Oelke M, Bachmann A, Descazeaud M, et al. Guidelines on conservative treatment of non-neurogenic male LUTS. EAU; 2010 http://www.uroweb.org/gls/pdf/BPH%202010.pdf.
Andersson K-E et al. The pharmacological treatment of nocturia. BJU Int. 2002;90 Suppl 3:25–7.
Weiss JP, Yea C, Nathadwarawala M, Marks BK, Imnadze M. Novel non-peptide pharmacologic therapy for nocturia in men. J Urol. 2010;183(4):e590.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Weiss, J.P. (2012). Introduction. In: Weiss, MD, FACS, J., Blaivas, MD, J., Van Kerrebroeck, MD, PhD, MMSc, P., Wein, MD, FACS, PhD(hon), A. (eds) Nocturia. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1156-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1156-7_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1155-0
Online ISBN: 978-1-4614-1156-7
eBook Packages: MedicineMedicine (R0)